All In Biotech

Drug Trial Radar · NCT03044743

PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies

A Phase I/II Trial of PD-1 Knockout EBV-CTLs for Advanced Stage EBV Associated Malignancies

Last checked: Nov 19, 2026Latest source record: May 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Apr 7, 2017

Primary completion

Mar 2020

Study completion Mar 2022

Sponsor

Lead sponsor
Yang YangAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 7, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety of PD-1 knockout EBV-CTL cells in treating EBV (Epstein-Barr virus) positive advanced stage malignancies. Blood samples will also be collected for research purposes.

Conditions

  • Stage IV Gastric Carcinoma
  • Stage IV Nasopharyngeal Carcinoma
  • T-Cell Lymphoma Stage IV
  • Stage IV Adult Hodgkin Lymphoma
  • Stage IV Diffuse Large B-Cell Lymphoma

Interventions

  • FludarabineDrug

    To modify immune micro-environment

  • CyclophosphamideDrug

    To modify immune micro-environment

  • Interleukin-2Drug

    To sustain the survival of infused T cells

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with Adverse Events using Common Terminology Criteria for Adverse Events (CTCAE v4.0) in patientsTime frame: 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • The Comprehensive Cancer Center of Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

  • The Comprehensive Cancer Center of Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.